Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies – DocWire News

Front Immunol. 2021 Oct 4;12:727850. doi: 10.3389/fimmu.2021.727850. eCollection 2021.
ABSTRACT
Mass SARS-Cov-2 vaccination campaign represents the only strategy to defeat the global pandemic we are facing. Immunocompromised patients represent a vulnerable…

Click here to view the original article.